Best Treatments for Persistent Post-Traumatic Headache in 2026

Persistent post-traumatic headache (PPTH) is one of the most common and disabling consequences of traumatic brain injury. Nearly half of TBI patients develop headache that persists well beyond the initial recovery window, and for many, it becomes a chronic condition lasting years. If you are living with headache that started after a concussion or head injury and has not resolved after three months, you are not alone, and you have more treatment options today than at any point in the past.

What makes PPTH especially frustrating is that the original injury may have healed, but the headache remains. Research now shows this is not a sign of ongoing damage. Instead, it reflects altered brain pain processing, including neuroinflammation, trigeminal nerve sensitization, and altered connectivity between brain regions that govern pain, emotion, and attention. Understanding this mechanism is key to choosing the right treatment, because the approaches with the strongest emerging evidence for PPTH are the ones that target the nervous system directly, not just the symptoms.

This guide ranks seven evidence-based treatment categories for persistent post-traumatic headache in 2026, starting with the approaches that address the root neuroplastic changes driving the condition.

Key Takeaways

• Persistent post-traumatic headache affects roughly half of people who sustain a traumatic brain injury, with headache persisting beyond one year in an estimated 58% of those affected.
• PPTH is increasingly understood as a disorder of central sensitization and neuroplastic change, not ongoing tissue damage, which is why brain-based treatments show growing promise.
• Behavioral therapies like CBT, ACT, and pain reprocessing therapy reduce headache frequency and disability in adults with chronic headache conditions, with durable effects.
• Preventive medications, neuromodulation devices, and nerve blocks each have a role, but evidence specifically for PPTH remains more limited than for primary migraine.
• A combined approach, pairing behavioral and lifestyle strategies with targeted medical treatment, often produces stronger outcomes than any single approach for people with PPTH.

1. Brain-Based Behavioral Therapy

Brain-based behavioral therapy targets the neuroplastic changes that keep the pain alarm firing after the original injury has healed. For people with PPTH, this means addressing the fear-avoidance cycles, emotional distress, and learned pain responses that sustain headache through central sensitization rather than structural damage.

This category includes several specific modalities, each with its own evidence base: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), pain reprocessing therapy (PRT), and somatic tracking. What they share is a focus on retraining the brain's response to pain signals rather than suppressing symptoms.

How It Works

After a traumatic brain injury, the trigeminal pain pathways and brain regions involved in pain processing can become sensitized. Pro-inflammatory cytokines activate nociceptive nerve fibers, while glial cells in the brainstem release mediators that perpetuate neural sensitization. Over time, the brain's pain-processing networks reorganize, pain signals persist even after tissue healing, and the headache becomes self-reinforcing.

Behavioral therapies interrupt this cycle. CBT helps identify and restructure thought patterns that amplify pain perception. ACT builds psychological flexibility so pain does not dominate daily functioning. PRT and somatic tracking work by reappraising pain sensations as non-dangerous brain signals, reducing the threat response that keeps the nervous system on high alert.

What the Evidence Shows

A 2025 systematic review and meta-analysis of 63 randomized trials found that CBT reduces migraine and headache attacks by approximately 1.1 fewer days per month in adults, with relaxation training and mindfulness-based therapies showing similar reductions. These effects are comparable in magnitude to established preventive medications.

For ACT specifically, a 2024 meta-analysis of 21 randomized controlled trials found reduced pain and improved mood in adults with chronic pain conditions, with improvements in pain acceptance and psychological flexibility.

Pain reprocessing therapy is newer but showing striking early results. The first published case series on PRT for migraine, published in 2025 in Headache: The Journal of Head and Face Pain, reported that individuals with chronic migraine experienced large headache frequency reductions, dropping from 18-30 headache days per month to 3-5 days. The improvements appeared to follow a shift in pain attribution toward understanding headache as a learned neural pattern rather than a sign of ongoing damage.

Who May Benefit

Brain-based behavioral therapy is well-suited for adults with PPTH who have persistent headache despite medical treatment, particularly when fear of movement, emotional distress, sleep disruption, or avoidance behaviors are amplifying the headache cycle. It is also appropriate for people who want to reduce reliance on medication or who have not responded to pharmacological approaches alone.

These therapies work alongside medical treatment, not as a replacement. A combined approach tends to produce the strongest outcomes.

2. Preventive Medications

Preventive medications aim to reduce the frequency and severity of PPTH episodes rather than treating individual attacks. Because PPTH frequently presents with migraine-like features, clinicians often draw from the migraine prevention evidence base when choosing medications.

Tricyclic Antidepressants

Amitriptyline is one of the most commonly prescribed preventive medications for post-traumatic headache. It works by modulating serotonin and norepinephrine pathways involved in pain processing. In a pilot randomized trial of U.S. Army soldiers with chronic post-traumatic headache, amitriptyline reduced headache days by 41% (from 11.7 to 6.1 days per month), though no prophylactic treatment outperformed placebo in that trial due to a high placebo response rate. Amitriptyline also has the advantage of addressing comorbid sleep disturbance and tension-type headache features, both common in PPTH.

Anticonvulsants

Topiramate is an established first-line medication for migraine prevention that also shows promise for PPTH. In the same military trial, topiramate was the only treatment that also improved co-occurring PTSD symptoms, a notable benefit given the high overlap between PPTH and post-traumatic stress. Side effects including cognitive slowing, weight loss, and tingling are common and should be discussed with a prescribing clinician.

CGRP Monoclonal Antibodies

Calcitonin gene-related peptide (CGRP) monoclonal antibodies represent the newest class of preventive migraine medication. Erenumab, fremanezumab, galcanezumab, and eptinezumab are all approved for migraine prevention. However, the evidence for PPTH specifically is mixed. An open-label study of erenumab in 89 patients with post-traumatic headache found a modest headache day reduction of approximately 1.7 days per month, while a phase 2 trial of fremanezumab did not demonstrate significant efficacy over placebo for PPTH.

This suggests that CGRP alone may not suffice for post-traumatic headache, which involves neuroinflammation and central sensitization beyond the CGRP pathway.

Who May Benefit

Preventive medications are typically considered for adults with PPTH who experience eight or more headache days per month, have significant functional impairment, or have not responded adequately to acute treatments. The choice of medication depends on headache phenotype, comorbid conditions, and individual tolerance.

3. OnabotulinumtoxinA (Botox) Injections

OnabotulinumtoxinA is FDA-approved for chronic migraine prevention and is increasingly used off-label for PPTH when the headache phenotype resembles chronic migraine (15 or more headache days per month).

How It Works

OnabotulinumtoxinA works through multiple mechanisms. It inhibits the release of pain-signaling molecules including CGRP, substance P, and glutamate from sensory nerve terminals. It also reduces peripheral sensitization of pain fibers, which may help interrupt the cycle of central sensitization that maintains PPTH. This broader mechanism of action is one reason some researchers believe it may outperform CGRP-targeting therapies for the complex pathophysiology of post-traumatic headache.

What the Evidence Shows

In a military cohort of 64 soldiers with post-traumatic headache, 64% reported improvement after onabotulinumtoxinA treatment at doses of 155-200 units. A randomized controlled trial with abobotulinumtoxin A in 40 subjects found a significant reduction in headache days per week and headache intensity. Preclinical research from 2025 also suggests that onabotulinumtoxinA may help prevent the dysregulation of descending pain control following mild traumatic brain injury, potentially slowing the transition from acute to persistent headache.

Evidence quality remains moderate, and larger controlled trials are needed. Treatments are typically administered every 12 weeks and may take two to three cycles before full benefit becomes apparent.

Who May Benefit

OnabotulinumtoxinA is most appropriate for adults with PPTH who meet the chronic migraine phenotype (15+ headache days per month), have not responded adequately to two or more preventive medications, and can commit to quarterly injections. It is generally well-tolerated, with injection-site pain and temporary neck weakness as the most common side effects.

4. Non-Invasive Neuromodulation Devices

Non-invasive neuromodulation devices deliver electrical or magnetic stimulation to specific nerve pathways to reduce headache frequency and intensity. Several FDA-cleared devices are now available for home use, making them an accessible option for people with PPTH.

External Trigeminal Nerve Stimulation (Cefaly)

Cefaly is a wearable device that stimulates the supraorbital branches of the trigeminal nerve through an electrode placed on the forehead. The International Headache Society issued 2025 neuromodulation guidelines providing a weak recommendation for Cefaly in both acute and preventive migraine treatment. While specific PPTH trials are limited, the device's mechanism of modulating trigeminal sensitization makes it a reasonable option given the trigeminal role in PPTH.

Non-Invasive Vagus Nerve Stimulation (gammaCore)

GammaCore delivers electrical stimulation to the vagus nerve through the skin of the neck. A 2025 case report documented reduced headache intensity and frequency in a veteran with chronic post-traumatic headache and comorbid mood disorders. The vagus nerve influences both pain processing and neuroinflammation, making this device mechanistically relevant for PPTH.

Neurofeedback

Infra-low frequency neurofeedback, a form of brain-computer interface training, has shown promise in a 2025 randomized controlled trial for post-concussive symptoms including headache, sleep, and attention difficulties. This approach trains patients to modulate their own brain activity patterns, potentially addressing the maladaptive neural connectivity changes seen in persistent post-concussion symptoms.

Who May Benefit

Neuromodulation devices are appropriate for adults with PPTH who prefer non-pharmacological options, want to reduce medication use, or have contraindications to preventive medications. They can be used alongside other treatments. The evidence base for these devices in PPTH specifically is still developing, so discuss expectations with a treating clinician.

5. Physical Therapy and Vestibular Rehabilitation

Physical therapy for PPTH goes beyond traditional manual therapy. Specialized approaches target the cervical spine dysfunction, vestibular impairment, and exercise intolerance that commonly accompany post-traumatic headache.

Cervical Spine Manual Therapy

Many people with PPTH have concurrent cervicogenic headache features, where dysfunction in the upper cervical spine contributes to headache. Manual therapy techniques targeting the cervical spine, including joint mobilization and soft tissue work, can reduce headache frequency when cervical involvement is confirmed through clinical examination.

Vestibular Rehabilitation

Vestibular dysfunction is present in a significant proportion of people with persistent post-concussion symptoms. A 2026 review of vestibular rehabilitation after concussion described it as an evidence-based intervention that addresses dizziness, balance impairment, and motion sensitivity, all of which can exacerbate headache. Multiple systematic reviews from 2023-2025 support vestibular rehabilitation as part of a comprehensive concussion recovery program, particularly when vestibular symptoms are present alongside headache.

Sub-Symptom Threshold Aerobic Exercise

Structured aerobic exercise is one of the most well-supported interventions for persistent post-concussion symptoms. A 2025 systematic review of randomized controlled trials found that aerobic exercise reduces concussion-related symptoms when performed at sub-symptom threshold intensity. Research published in Neuroscience in 2026 demonstrated that exercise counteracts neuroinflammation-driven maladaptive neuroplasticity in post-traumatic headache models, reducing pro-inflammatory cytokines while increasing anti-inflammatory markers.

The key is graduated intensity. Starting below symptom-exacerbation thresholds and progressively increasing allows the cardiovascular and autonomic systems to recalibrate without triggering headache flares.

Who May Benefit

Physical therapy and vestibular rehabilitation are appropriate for adults with PPTH who have dizziness, balance problems, neck pain, or exercise intolerance. A clinician experienced in concussion management can determine which combination of manual therapy, vestibular exercises, and aerobic conditioning is most relevant.

6. Nerve Blocks and Interventional Procedures

Interventional procedures provide targeted pain relief by blocking nerve signaling at specific anatomical sites. They are typically reserved for people with moderate-to-severe PPTH who have not responded adequately to conservative treatments.

Greater Occipital Nerve Block

The greater occipital nerve is a common contributor to headache in PPTH. Injecting a local anesthetic (sometimes combined with a corticosteroid) around this nerve can provide weeks to months of headache relief. A retrospective study of postconcussive patients found that 80% reported good symptom relief, with symptom reduction lasting weeks. The procedure is well-tolerated, takes minutes to perform, and can be repeated.

Occipital nerve blocks also serve a diagnostic function: a positive response helps confirm that the occipital nerve is contributing to the headache pattern, which guides further treatment decisions.

Trigger Point Injections

Myofascial trigger points in the cervical and pericranial muscles are common in people with PPTH, particularly those with tension-type headache features. Injecting these trigger points with local anesthetic can reduce muscle-related headache contribution and improve response to other treatments.

Who May Benefit

Nerve blocks are appropriate for adults with PPTH who have occipital or cervicogenic headache features, have not responded fully to behavioral and pharmacological approaches, or need a bridge treatment while other therapies take effect. They tend to work well as part of a multimodal treatment plan rather than as a standalone approach.

7. Lifestyle and Integrative Strategies

Lifestyle modifications form the foundation of any PPTH treatment plan. While they rarely eliminate headache on their own, they create the conditions under which other treatments work more effectively.

Sleep Optimization

Sleep disruption is both a consequence and a driver of PPTH. Poor sleep increases central sensitization, lowers pain thresholds, and amplifies emotional reactivity to pain. Establishing consistent sleep-wake times, limiting screen exposure before bed, and treating any concurrent sleep disorders (insomnia, sleep apnea) can meaningfully reduce headache burden. Cognitive behavioral therapy for insomnia (CBT-I) has a strong evidence base and avoids the rebound effects associated with sleep medications.

Stress Management and Biofeedback

Stress is one of the most consistently reported headache triggers in people with PPTH. Biofeedback, which trains patients to gain voluntary control over physiological responses like muscle tension and heart rate variability, has shown promise for persistent post-traumatic headache in both adults and adolescents. A 2025 randomized controlled trial of infra-low frequency neurofeedback also demonstrated benefits for post-concussive headache.

Mindfulness-based interventions reduce headache frequency by approximately 1.0 fewer day per month in adults with migraine, and a pilot program, OWNMindfulness, was designed for post-concussion recovery.

Dietary and Environmental Trigger Identification

While PPTH triggers vary between individuals, common ones include dehydration, caffeine fluctuation, alcohol, processed foods, bright or flickering lights, and loud environments. Keeping a headache diary to track patterns can help identify modifiable triggers. Imaginal exposure techniques can also help reduce sensitivity to unavoidable triggers over time.

Who May Benefit

Every person with PPTH benefits from lifestyle optimization. These strategies are low-risk, low-cost, and can be started immediately. They are especially important for people in the early months after injury when the brain is still recovering, and for those who want to minimize medication use.

How Lin Health Helps with Post-Traumatic Headache

Persistent post-traumatic headache often persists because the brain's pain alarm gets stuck after the initial injury has healed. The tissue damage resolves, but the nervous system continues firing danger signals, creating a self-reinforcing cycle of pain, fear, and avoidance. This is the same neuroplastic mechanism that drives many chronic pain conditions, and it is exactly what Lin Health's program is designed to address.

Lin Health's approach is based on findings from neuroplastic pain research, including CBT, ACT, pain reprocessing therapy, and somatic tracking. The program is delivered by trained recovery coaches through weekly live sessions, between-session chat support, and an app with structured learning and practice materials. Each module is designed by clinical experts and protocolized for consistent quality.

For people with chronic migraine and headache conditions, Lin Health focuses on breaking the fear-avoidance cycle, reframing pain signals as non-dangerous neural output, addressing emotional and cognitive patterns that amplify headache, and building practical self-management skills. The program works alongside medical treatment, not as a replacement.

Lin Health is covered by most major insurance plans in Colorado, Texas, Florida, California, and New York, with coverage expanding to additional states. Most patients pay nothing out of pocket. Wait times are short, and you can typically get a same-day callback after signing up. Lin Health also partners with leading headache and neurology centers, including the NY Headache Center and the Summit Headache and Neurological Institute.

If you have been living with headache since a concussion or head injury and conventional treatments have not been enough on their own, behavioral approaches that target the neuroplastic roots of persistent headache may be worth exploring. See if Lin Health helps, with most patients fully covered by insurance and short wait times to get started.

FAQ

What is persistent post-traumatic headache?

Persistent post-traumatic headache is a headache that develops within seven days of a traumatic brain injury (or after regaining consciousness) and lasts longer than three months. It is classified under ICHD-3 diagnostic criteria and affects roughly half of people who sustain a TBI.

Why does my headache continue after my concussion has healed?

After the initial injury resolves, the brain's pain-processing pathways can remain sensitized through neuroinflammation and central sensitization. Pain signals continue firing even without ongoing tissue damage, creating what researchers describe as a neuroplastic or learned pain pattern.

Can behavioral therapy really help with a headache caused by a head injury?

Yes. Behavioral therapies including CBT, ACT, and pain reprocessing therapy have evidence supporting their use for chronic headache conditions. A 2025 meta-analysis of 63 trials found that CBT reduces headache attacks by approximately 1.1 fewer days per month in adults, and early PRT case studies show larger reductions in chronic migraine frequency.

What is the difference between PPTH and chronic migraine?

PPTH is defined by its cause (traumatic brain injury), while chronic migraine is defined by frequency (15+ headache days per month for 3+ months). Many people with PPTH develop a migraine-like phenotype, which is why migraine treatments are often effective for PPTH as well. However, PPTH can also present with tension-type or mixed features.

Are CGRP monoclonal antibodies effective for post-traumatic headache?

The evidence is mixed. While CGRP monoclonal antibodies are well-established for migraine prevention, a phase 2 trial of fremanezumab did not show significant efficacy specifically for PPTH. An open-label study of erenumab showed a modest reduction of about 1.7 headache days per month. CGRP inhibition alone may not fully address the multiple mechanisms driving PPTH.

How long does it take to see improvement with treatment?

This varies by treatment. Behavioral therapies typically show measurable improvement within 6-12 weeks of consistent engagement. Preventive medications may take 8-12 weeks at therapeutic doses. OnabotulinumtoxinA often requires two to three treatment cycles (6-9 months) before full benefit is apparent.

Should I combine multiple treatments?

For most people with PPTH, a multimodal approach produces the strongest results. Pairing brain-based behavioral therapy with appropriate medical treatment, lifestyle modifications, and physical rehabilitation addresses the condition from multiple angles and tends to produce more durable improvement than any single approach.

This article is for informational purposes and is not medical advice. Consult a qualified healthcare provider before making changes to your treatment plan.